Literature DB >> 3984736

Prostatic carcinoma reproducibility of histologic grading.

H Svanholm, H Mygind.   

Abstract

The inter- and intraobserver variations of the histologic grading systems of prostatic carcinoma proposed by Gleason and by Böcking et al. were tested by the authors. Both grading systems have previously been shown to have good correlation with prognosis. After studying 91 cases of prostatic carcinomas, the interobserver agreements of the Gleason pattern score and the Böcking combined grade were found to be 36% and 69% respectively. Both observers regraded 31 randomly selected prostatic carcinomas. With the Gleason pattern score intraobserver agreements of 65% and 42% were found, whereas the intraobserver agreements of the Böcking combined grade were 90% and 71% respectively. Since the percentages of inter- and intraobserver agreements were higher with the system of Böcking et al., this system is recommended prior to the system of Gleason as a means of evaluating the prognosis of patients with prostatic carcinoma.

Entities:  

Mesh:

Year:  1985        PMID: 3984736     DOI: 10.1111/j.1699-0463.1985.tb03921.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand A        ISSN: 0108-0164


  6 in total

1.  Intraobserver and interobserver reproducibility of WHO and Gleason histologic grading systems in prostatic adenocarcinomas.

Authors:  S O Ozdamar; S Sarikaya; L Yildiz; M K Atilla; B Kandemir; S Yildiz
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

Review 2.  Reproducibility and reliability of tumor grading in urological neoplasms.

Authors:  Rainer Engers
Journal:  World J Urol       Date:  2007-09-09       Impact factor: 4.226

3.  Histologic grading of prostatic adenocarcinoma: intraobserver reproducibility of the Mostofi, Gleason and Böcking grading systems.

Authors:  M L Cintra; A Billis
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

4.  Interobserver reproducibility of Gleason grading: evaluation using prostate cancer tissue microarrays.

Authors:  M Burchardt; R Engers; M Müller; T Burchardt; R Willers; J I Epstein; R Ackermann; H E Gabbert; A de la Taille; M A Rubin
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-08       Impact factor: 4.553

5.  Stereologically estimated mean nuclear volume of prostatic cancer is a reliable prognostic parameter.

Authors:  K Arima; Y Sugimura; T Hioki; A Yamashita; J Kawamura
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Should active surveillance in prostate cancer patients be based on a single histological assessment?

Authors:  Lukasz Nyk; Tomasz Golabek; Jakub Dobruch; Michał Andrzej Skrzypczyk; Tomasz Dzik; Maciej Wysocki; Piotr L Chłosta; Andrzej Borówka
Journal:  Cent European J Urol       Date:  2014-08-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.